RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Cyteir Therapeutics Stock

Cyteir Therapeutics Equity 2024

Cyteir Therapeutics Equity

146.3 M USD

Ticker

CYT

ISIN

US23284P1030

In 2024, Cyteir Therapeutics's equity was 146.3 M USD, a -21.89% increase from the 187.3 M USD equity in the previous year.

Cyteir Therapeutics Aktienanalyse

What does Cyteir Therapeutics do?

Cyteir Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Cyteir Therapeutics's Equity

Cyteir Therapeutics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Cyteir Therapeutics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Cyteir Therapeutics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Cyteir Therapeutics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Cyteir Therapeutics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Cyteir Therapeutics stock

What is the equity of Cyteir Therapeutics this year?

Cyteir Therapeutics has equity of 146.3 M USD this year.

What was the equity of Cyteir Therapeutics compared to the previous year?

The equity of Cyteir Therapeutics has increased/decreased by -21.89% decreased compared to the previous year.

What impact does a high equity have on investors of Cyteir Therapeutics?

A high equity is advantageous for investors of Cyteir Therapeutics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Cyteir Therapeutics?

A low equity can be a risk for investors of Cyteir Therapeutics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Cyteir Therapeutics affect the company?

An increase in equity of Cyteir Therapeutics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Cyteir Therapeutics affect the company?

A reduction in equity of Cyteir Therapeutics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Cyteir Therapeutics?

Some factors that can affect the equity of Cyteir Therapeutics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Cyteir Therapeutics so important for investors?

The equity of Cyteir Therapeutics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Cyteir Therapeutics take to change the equity?

To change equity, Cyteir Therapeutics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Cyteir Therapeutics pay?

Over the past 12 months, Cyteir Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Cyteir Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Cyteir Therapeutics?

The current dividend yield of Cyteir Therapeutics is .

When does Cyteir Therapeutics pay dividends?

Cyteir Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Cyteir Therapeutics?

Cyteir Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Cyteir Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Cyteir Therapeutics located?

Cyteir Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Cyteir Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Cyteir Therapeutics from 10/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.

When did Cyteir Therapeutics pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of Cyteir Therapeutics in the year 2023?

In the year 2023, Cyteir Therapeutics distributed 0 USD as dividends.

In which currency does Cyteir Therapeutics pay out the dividend?

The dividends of Cyteir Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Cyteir Therapeutics

Our stock analysis for Cyteir Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cyteir Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.